glp-1 receptor expression papillary thyroid carcinoma of GLP-1R, GIPR, and GCGR in human tumor tissues. Tumor Risk of pancreatic cancer associated

The TRIUMPH clinical trial program is evaluating retatrutide for multiple indications beyond simple weight loss, including obesity with osteoarthritis, obesity with metabolic complications, type 2 diabetes, cardiovascular outcomes, obstructive sleep apnea, and metabolic dysfunction-associated steatohepatitis

B.VangK.et al (2016)

Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study

Eat more protein and fiber

Without clinical trial data, the effectiveness is unclear

GLP-1 receptor agonists like semaglutide (Wegovy), tirzepatide (Zepbound), and liraglutide (Saxenda) work through multiple mechanisms to improve blood sugar control and promote weight loss